269 related articles for article (PubMed ID: 34999396)
41. Phytochemical gallic acid alleviates nonalcoholic fatty liver disease via AMPK-ACC-PPARa axis through dual regulation of lipid metabolism and mitochondrial function.
Zhang J; Zhang W; Yang L; Zhao W; Liu Z; Wang E; Wang J
Phytomedicine; 2023 Jan; 109():154589. PubMed ID: 36610145
[TBL] [Abstract][Full Text] [Related]
42. Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis.
Lee DH; Han DH; Nam KT; Park JS; Kim SH; Lee M; Kim G; Min BS; Cha BS; Lee YS; Sung SH; Jeong H; Ji HW; Lee MJ; Lee JS; Lee HY; Chun Y; Kim J; Komatsu M; Lee YH; Bae SH
Free Radic Biol Med; 2016 Oct; 99():520-532. PubMed ID: 27634173
[TBL] [Abstract][Full Text] [Related]
43. Atractylenolide III ameliorates Non-Alcoholic Fatty Liver Disease by activating Hepatic Adiponectin Receptor 1-Mediated AMPK Pathway.
Li Q; Tan JX; He Y; Bai F; Li SW; Hou YW; Ji LS; Gao YT; Zhang X; Zhou ZH; Yu Z; Fang M; Gao YQ; Li M
Int J Biol Sci; 2022; 18(4):1594-1611. PubMed ID: 35280674
[No Abstract] [Full Text] [Related]
44. Serine prevented high-fat diet-induced oxidative stress by activating AMPK and epigenetically modulating the expression of glutathione synthesis-related genes.
Zhou X; He L; Zuo S; Zhang Y; Wan D; Long C; Huang P; Wu X; Wu C; Liu G; Yin Y
Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):488-498. PubMed ID: 29158183
[TBL] [Abstract][Full Text] [Related]
45. Loss of RIP3 initiates annihilation of high-fat diet initialized nonalcoholic hepatosteatosis: A mechanism involving Toll-like receptor 4 and oxidative stress.
Chenxu G; Minxuan X; Yuting Q; Tingting G; Jing F; Jinxiao L; Sujun W; Yongjie M; Deshuai L; Qiang L; Linfeng H; Xuyuan N; Mingxing W; Ping H; Jun T
Free Radic Biol Med; 2019 Apr; 134():23-41. PubMed ID: 30599260
[TBL] [Abstract][Full Text] [Related]
46. Zanthoxylum bungeanum amides ameliorates nonalcoholic fatty liver via regulating gut microbiota and activating AMPK/Nrf2 signaling.
Peng W; He CX; Li RL; Qian D; Wang LY; Chen WW; Zhang Q; Wu CJ
J Ethnopharmacol; 2024 Jan; 318(Pt A):116848. PubMed ID: 37423515
[TBL] [Abstract][Full Text] [Related]
47. Carnosol alleviates nonalcoholic fatty liver disease by inhibiting mitochondrial dysfunction and apoptosis through targeting of PRDX3.
Geng Y; Wang Y; Sun R; Kang X; Zhao H; Zhu M; Sun Y; Hu Y; Wang Z; Tian X; Zhao Y; Yao J
Toxicol Appl Pharmacol; 2021 Dec; 432():115758. PubMed ID: 34678374
[TBL] [Abstract][Full Text] [Related]
48. Liraglutide ameliorates obesity-related nonalcoholic fatty liver disease by regulating Sestrin2-mediated Nrf2/HO-1 pathway.
Han X; Ding C; Zhang G; Pan R; Liu Y; Huang N; Hou N; Han F; Xu W; Sun X
Biochem Biophys Res Commun; 2020 May; 525(4):895-901. PubMed ID: 32171530
[TBL] [Abstract][Full Text] [Related]
49. Dehydroepiandrosterone protects against oleic acid-triggered mitochondrial dysfunction to relieve oxidative stress and inflammation via activation of the AMPK-Nrf2 axis by targeting GPR30 in hepatocytes.
Yao Y; Wang H; Yang Y; Jiang Z; Ma H
Mol Immunol; 2023 Mar; 155():110-123. PubMed ID: 36773597
[TBL] [Abstract][Full Text] [Related]
50. Intermittent hypoxia aggravates non-alcoholic fatty liver disease via RIPK3-dependent necroptosis-modulated Nrf2/NFκB signaling pathway.
Zhang H; Zhou L; Zhou Y; Wang L; Jiang W; Liu L; Yue S; Zheng P; Liu H
Life Sci; 2021 Nov; 285():119963. PubMed ID: 34536498
[TBL] [Abstract][Full Text] [Related]
51. Salidroside and Curcumin Formula Prevents Liver Injury in Nonalcoholic Fatty Liver Disease in Rats.
Li HS
Ann Hepatol; 2018 Aug; 17(5):769-778. PubMed ID: 30145577
[TBL] [Abstract][Full Text] [Related]
52. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
Castaño D; Larequi E; Belza I; Astudillo AM; Martínez-Ansó E; Balsinde J; Argemi J; Aragon T; Moreno-Aliaga MJ; Muntane J; Prieto J; Bustos M
J Hepatol; 2014 May; 60(5):1017-25. PubMed ID: 24362075
[TBL] [Abstract][Full Text] [Related]
53. Tumor Necrosis Factor α-Induced Protein 8-Like 2 Alleviates Nonalcoholic Fatty Liver Disease Through Suppressing Transforming Growth Factor Beta-Activated Kinase 1 Activation.
Liu Y; Song J; Yang J; Zheng J; Yang L; Gao J; Tian S; Liu Z; Meng X; Wang JC; Dai Z; Tang YD
Hepatology; 2021 Sep; 74(3):1300-1318. PubMed ID: 33768585
[TBL] [Abstract][Full Text] [Related]
54. Zingerone ameliorates non-alcoholic fatty liver disease in rats by activating AMPK.
Mohammed HM
J Food Biochem; 2022 Jul; 46(7):e14149. PubMed ID: 35338494
[TBL] [Abstract][Full Text] [Related]
55. Niacin inhibits fat accumulation, oxidative stress, and inflammatory cytokine IL-8 in cultured hepatocytes: Impact on non-alcoholic fatty liver disease.
Ganji SH; Kashyap ML; Kamanna VS
Metabolism; 2015 Sep; 64(9):982-90. PubMed ID: 26024755
[TBL] [Abstract][Full Text] [Related]
56. Suppressing NLRP2 expression accelerates hepatic steatosis: A mechanism involving inflammation and oxidative stress.
Li C; Liu Q; Xie L
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):22-29. PubMed ID: 30454891
[TBL] [Abstract][Full Text] [Related]
57. Bouchardatine analogue alleviates non-alcoholic hepatic fatty liver disease/non-alcoholic steatohepatitis in high-fat fed mice by inhibiting ATP synthase activity.
Rao Y; Lu YT; Li C; Song QQ; Xu YH; Xu Z; Hu YT; Yu H; Gao L; Gu LQ; Ye JM; Huang ZS
Br J Pharmacol; 2019 Aug; 176(16):2877-2893. PubMed ID: 31113010
[TBL] [Abstract][Full Text] [Related]
58. Ameliorative effects and molecular mechanisms of vine tea on western diet-induced NAFLD.
Xie K; He X; Chen K; Sakao K; Hou DX
Food Funct; 2020 Jul; 11(7):5976-5991. PubMed ID: 32666969
[TBL] [Abstract][Full Text] [Related]
59. Alpha-naphthoflavone attenuates non-alcoholic fatty liver disease in oleic acid-treated HepG2 hepatocytes and in high fat diet-fed mice.
Xia H; Zhu X; Zhang X; Jiang H; Li B; Wang Z; Li D; Jin Y
Biomed Pharmacother; 2019 Oct; 118():109287. PubMed ID: 31401392
[TBL] [Abstract][Full Text] [Related]
60. Patchouli alcohol ameliorates skeletal muscle insulin resistance and NAFLD via AMPK/SIRT1-mediated suppression of inflammation.
Pyun DH; Kim TJ; Park SY; Lee HJ; Abd El-Aty AM; Jeong JH; Jung TW
Mol Cell Endocrinol; 2021 Dec; 538():111464. PubMed ID: 34601002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
